Estado del programa
ReclutamientoFase
Fase 1Inmunoterapia previa permitida
NoEnsayo dirigido por el CRC
SíEtiquetas
MSI-H/ MMRd, MSS/ MMRp| Ubicación | Situación |
|---|---|
| Noruega | |
|
Hospital Universitario de Oslo Oslo 0424 Oslo |
Reclutamiento |
Contactos
Criterios de inclusión
Criterios de inclusión:
Histologically verified adenocarcinoma in colon/rectum.
Liver metastases, not amenable to liver resection
No signs of extra hepatic metastatic disease or local recurrence according to PET/CT scan within 4 weeks prior to the faculty meeting at the transplant unit, except patients may have 1-3 resectable lung lesions all<15mm.
No signs of extra hepatic metastatic disease on CT thorax/abdomen/pelvis within 4 weeks prior to the faculty meeting at the transplant unit, except patients may have 1-3 resectable lung lesions all10g/dl, neutrophiles >1.0 (after any G-CSF), TRC >75, Bilirubin<2 x upper normal level, ASAT,ALAT<5 x upper normal level, Creatinine 10% the last 6 months
Patient BMI > 30
Previous diagnosed bone or CNS metastatic disease.
Previous diagnosed cancer mammae or malignant melanoma.
Palliative resection of primary CRC tumor.
